Aaron Royston - 09 Jun 2022 Form 4/A - Amendment Insider Report for Ventyx Biosciences, Inc. (VTYX)

Reporting relationship: Director
Issuer ticker: VTYX
Reported as of: 09 Jun 2022
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 26 Apr 2023, 20:31:48 UTC
Original report date: 10 Jun 2022
Prior SEC filing: 25 Oct 2021
Next SEC filing: 14 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ Christopher Krueger, as Attorney-in-Fact

Key filing fact

Aaron Royston filed Form 4/A - Amendment for Ventyx Biosciences, Inc. (VTYX) on 26 Apr 2023.

Key facts

This page summarizes Aaron Royston's Form 4/A - Amendment filing for Ventyx Biosciences, Inc. (VTYX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Apr 2023, 20:31.

Change

Previous filing in this sequence was filed on 25 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTYX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +21,825
Change %
Price: $0.000000
Shares after: 21,825
Date: 09 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,825
Exercise price: $16.54
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Form 4 filed on June 10, 2022, erroneously reported that the reporting person received an option award for 13,301 shares on June 9, 2022. The correct option award amount is for 21,825 shares.

Footnote F2

The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the reporting person continuing to be Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date.